220
Participants
Start Date
June 1, 2022
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2028
radioembolization
holmium-166 microspheres
Standard of care first-line systemic therapy
Capecitabine plus anti-VEGF antibody
RECRUITING
UMC Utrecht, Utrecht
Dutch Colorectal Cancer Group
OTHER
UMC Utrecht
OTHER